International Severe Asthma Registry_Hong Kong
Recruiting · NCT07524543 · Observational (researchers observe without assigning treatment) · Lead sponsor: Chinese University of Hong Kong
View the official record on ClinicalTrials.gov →What this trial is about
To ensure the care of people with severe asthma continues to improve, it is essential we have detailed information on the health and treatment of as many people with the condition as possible. The purpose of the registry is to gather this information and track the progress of patients and how well they are responding to treatment. Medical research using data from the registry will provide a better understanding of asthma and help to develop and improve the care and treatment for patients with asthma. Detailed protocol can be referred to the reference in this trial registration (International severe asthma registry \[ISAR\]: protocol for a global registry).
Who can take part
Inclusion criteria
- Patient with severe asthma with age 18 or over will be recruited.
Exclusion criteria
- Patients who cannot provide written consent
Where it is running
1 location listed.
- The Chinese University of Hong Kong - Hong Kong, Hong Kong